Skip to content
10-K

Annual Report

Axogen, Inc. AXGN

0000805928-25-000017

← back to feed
Filed
Feb 26, 2025 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2024 · Feb 19, 2025 44.34M sh
Long Term Debt FY 2024 · Dec 31, 2023 $46.6M
Short Term Investments FY 2024 · Dec 31, 2023 $0
Cash And Equivalents FY 2024 · Dec 31, 2023 $31.02M
Current Liabilities FY 2024 · Dec 31, 2023 $30.43M
Total Liabilities FY 2024 · Dec 31, 2023 $101.16M
Current Assets FY 2024 · Dec 31, 2023 $88M
Total Assets FY 2024 · Dec 31, 2023 $196.83M
Shares Diluted FY 2024 · Dec 31, 2022 42.08M sh
Capex FY 2024 · Dec 31, 2022 $20.08M
Operating Cash Flow FY 2024 · Dec 31, 2022 −$16.07M
Eps Diluted FY 2024 · Dec 31, 2022 −$0.69
Eps Basic FY 2024 · Dec 31, 2022 −$0.69
Sga Expense restated FY 2024 · Dec 31, 2022 $40.91M
Rd Expense restated FY 2024 · Dec 31, 2022 $25.63M
Net Income FY 2024 · Dec 31, 2022 −$28.95M
Operating Income FY 2024 · Dec 31, 2022 −$29.71M
Gross Profit restated FY 2024 · Dec 31, 2022 $108.81M
Cost Of Revenue restated FY 2024 · Dec 31, 2022 $29.78M
Revenue FY 2024 · Dec 31, 2022 $138.58M
Stockholders Equity FY 2024 · Dec 31, 2021 $112.55M